Dose-Finding Safety Study Evaluating Remimazolam (CNS 7056) in Patients Undergoing Diagnostic Upper GI Endoscopy
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to assess the safety and efficacy of CNS 7056 as a procedural
sedative at three dose levels compared to midazolam during a diagnostic upper GI endoscopy.